Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also pr… Read more
Merck & Company Inc - Asset Resilience Ratio
Merck & Company Inc (MRK) has an Asset Resilience Ratio of 14.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Merck & Company Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Merck & Company Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $18.17 Billion | 14.03% |
| Short-term Investments | $45.00 Million | 0.03% |
| Total Liquid Assets | $18.21 Billion | 14.06% |
Asset Resilience Insights
- Moderate Liquidity: Merck & Company Inc has 14.06% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Merck & Company Inc Industry Peers by Asset Resilience Ratio
Compare Merck & Company Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
PINK:NVSEF |
Drug Manufacturers - General | 0.13% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 7.18% |
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
Drug Manufacturers - General | 5.75% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
Annual Asset Resilience Ratio for Merck & Company Inc (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Merck & Company Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.69% | $13.69 Billion | $117.11 Billion | +5.04pp |
| 2023-12-31 | 6.65% | $7.09 Billion | $106.67 Billion | -5.44pp |
| 2022-12-31 | 12.09% | $13.19 Billion | $109.16 Billion | +4.43pp |
| 2021-12-31 | 7.66% | $8.10 Billion | $105.69 Billion | -1.14pp |
| 2020-12-31 | 8.80% | $8.06 Billion | $91.59 Billion | -3.58pp |
| 2019-12-31 | 12.38% | $10.45 Billion | $84.40 Billion | +1.66pp |
| 2018-12-31 | 10.73% | $8.86 Billion | $82.64 Billion | +1.06pp |
| 2017-12-31 | 9.67% | $8.50 Billion | $87.87 Billion | -5.37pp |
| 2016-12-31 | 15.04% | $14.34 Billion | $95.38 Billion | +10.21pp |
| 2015-12-31 | 4.82% | $4.90 Billion | $101.68 Billion | -3.61pp |
| 2014-12-31 | 8.43% | $8.28 Billion | $98.17 Billion | +6.67pp |
| 2013-12-31 | 1.77% | $1.86 Billion | $105.64 Billion | -0.77pp |
| 2012-12-31 | 2.53% | $2.69 Billion | $106.13 Billion | +1.16pp |
| 2011-12-31 | 1.37% | $1.44 Billion | $105.13 Billion | +0.14pp |
| 2010-12-31 | 1.23% | $1.30 Billion | $105.78 Billion | +0.97pp |
| 2009-12-31 | 0.26% | $293.00 Million | $112.31 Billion | -2.11pp |
| 2008-12-31 | 2.37% | $1.12 Billion | $47.20 Billion | -3.62pp |
| 2007-12-31 | 5.99% | $2.89 Billion | $48.35 Billion | -0.29pp |
| 2006-12-31 | 6.28% | $2.80 Billion | $44.57 Billion | -7.22pp |
| 2005-12-31 | 13.50% | $6.05 Billion | $44.85 Billion | +3.60pp |
| 2004-12-31 | 9.89% | $4.21 Billion | $42.57 Billion | +2.57pp |
| 2003-12-31 | 7.32% | $2.97 Billion | $40.59 Billion | +1.59pp |
| 2002-12-31 | 5.74% | $2.73 Billion | $47.56 Billion | +3.14pp |
| 2001-12-31 | 2.60% | $1.14 Billion | $44.02 Billion | -1.71pp |
| 2000-12-31 | 4.30% | $1.72 Billion | $39.91 Billion | +0.99pp |
| 1999-12-31 | 3.31% | $1.18 Billion | $35.63 Billion | -- |